🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/01/2018 | 57,99 | 58,02 | 56,20 | 56,54 | -2,31% | 3,13% | 15.582.712 |
| 30/01/2018 | 58,01 | 58,44 | 57,67 | 57,87 | -1,59% | 1,33% | 13.666.654 |
| 29/01/2018 | 59,11 | 59,29 | 58,74 | 58,81 | -0,66% | 0,94% | 9.198.191 |
| 26/01/2018 | 58,67 | 59,24 | 58,53 | 59,20 | +1,21% | 1,20% | 11.060.278 |
| 25/01/2018 | 58,49 | 58,57 | 58,16 | 58,49 | +0,20% | 0,70% | 9.853.610 |
| 24/01/2018 | 59,17 | 59,27 | 58,17 | 58,38 | -0,84% | 1,85% | 14.129.241 |
| 23/01/2018 | 58,23 | 59,28 | 58,08 | 58,87 | +0,73% | 2,06% | 11.718.212 |
| 22/01/2018 | 58,16 | 58,63 | 57,94 | 58,44 | -0,05% | 1,18% | 12.835.380 |
| 19/01/2018 | 58,66 | 58,66 | 57,86 | 58,47 | +0,25% | 1,37% | 12.745.671 |
| 18/01/2018 | 59,16 | 59,27 | 57,85 | 58,33 | -1,45% | 2,40% | 20.861.278 |
| 17/01/2018 | 59,44 | 59,72 | 59,06 | 59,19 | -0,06% | 1,12% | 22.940.615 |
| 16/01/2018 | 58,92 | 60,86 | 58,44 | 59,23 | +5,81% | 4,10% | 50.399.682 |
| 12/01/2018 | 55,30 | 56,12 | 55,24 | 55,97 | +1,84% | 1,59% | 12.935.569 |
| 11/01/2018 | 54,68 | 54,97 | 54,54 | 54,96 | +0,52% | 0,79% | 7.447.402 |
| 10/01/2018 | 53,96 | 54,74 | 53,87 | 54,68 | +0,88% | 1,61% | 9.497.395 |
| 09/01/2018 | 54,21 | 54,48 | 53,98 | 54,20 | +0,25% | 0,93% | 11.142.022 |
| 08/01/2018 | 54,59 | 54,63 | 53,91 | 54,06 | -0,58% | 1,31% | 11.642.546 |
| 05/01/2018 | 54,76 | 54,76 | 54,00 | 54,38 | -0,11% | 1,39% | 9.955.057 |
| 04/01/2018 | 53,86 | 54,79 | 53,80 | 54,44 | +1,62% | 1,84% | 15.751.650 |
| 03/01/2018 | 53,65 | 53,68 | 53,40 | 53,57 | -0,14% | 0,53% | 11.090.460 |
| 02/01/2018 | 54,00 | 54,15 | 53,48 | 53,65 | -0,09% | 1,24% | 10.556.504 |
| 29/12/2017 | 54,23 | 54,38 | 53,69 | 53,69 | -0,58% | 1,27% | 8.841.557 |
| 28/12/2017 | 53,76 | 54,20 | 53,72 | 54,01 | +0,46% | 0,89% | 6.061.108 |
| 27/12/2017 | 53,81 | 54,04 | 53,68 | 53,76 | +0,00% | 0,66% | 5.931.994 |
| 26/12/2017 | 53,90 | 54,01 | 53,69 | 53,76 | -0,04% | 0,58% | 4.616.754 |
| 22/12/2017 | 54,01 | 54,23 | 53,56 | 53,78 | -0,42% | 1,24% | 11.890.608 |
| 21/12/2017 | 53,51 | 54,20 | 53,51 | 54,01 | +0,87% | 1,28% | 10.439.966 |
| 20/12/2017 | 53,70 | 53,90 | 53,42 | 53,54 | -0,21% | 0,91% | 13.766.423 |
| 19/12/2017 | 53,65 | 54,03 | 53,44 | 53,65 | +0,02% | 1,08% | 9.921.521 |
| 18/12/2017 | 53,80 | 54,09 | 53,63 | 53,65 | -0,04% | 0,87% | 12.151.560 |